People: Valeant Pharmaceuticals International Inc (VRX)
30 Jan 2015
Mr. Theo Melas-Kyriazi is Independent Director of Valeant Pharmaceuticals International Inc., since September 2010. He has been the Chief Financial Officer of Levitronix Technologies LLC, magnetically levitated bearingless motor technology, since 2011, and served as the Chief Financial Officer of its affiliate, Levitronix LLC since 2006. He was the Chief Financial Officer of Thermo Electron Corporation from January 1999 through October 2004. Mr. Melas-Kyriazi was a Vice President of Thermo Electron Corporation during 1998, in charge of corporate strategy; he served as the CEO of Thermo Spectra Corporation, a publicly-traded majority-owned subsidiary of Thermo Electron, from 1994 to 1998, and was Treasurer of Thermo Electron Corporation and all of its publicly traded subsidiaries from 1988 to 1994. Mr. Melas-Kyriazi is a former director of VPI, Helicos BioSciences Corporation, Cyberkinetics Neurotechnology Systems, Inc. and Glenrose Instruments Inc.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|